The MicroRNA (miRNA) Market is expected to register a CAGR of 13% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The MicroRNA (miRNA) Market report covers segmental analysis by Product (Instruments, Consumables), Services (Sample Collection, miRNA cDNA Synthesis, miRNA Profiling and Purification, Next Generation Sequencing (NGS), Microarray, Real Time PCR (RT-PCR), Others), Application (Cardiovascular Diseases, Cancer, Neurological Diseases, Immunological Disorders, Infectious Diseases, Others), End User (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken down at the regional level and major countries
Purpose of the ReportThe report MicroRNA (miRNA) Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
MicroRNA (miRNA) Market Segmentation
Product- Instruments
- Consumables
- Sample Collection
- miRNA cDNA Synthesis
- miRNA Profiling and Purification
- Next Generation Sequencing
- Microarray
- Real Time PCR
- Cardiovascular Diseases
- Cancer
- Neurological Diseases
- Immunological Disorders
- Infectious Diseases
- Biotechnology and Pharmaceutical Companies
- Academic and Government Research Institutes
Strategic Insights
MicroRNA (miRNA) Market Growth Drivers- Expanding Applications in Regenerative Medicine: Regenerative medicine encompasses the repairing or replacement of tissues and organs after damage. Here is a substantial impact area in which miRNAs intervene, enhancing the stem cell differentiation of tissues that eventually regenerate and heal the wounds. With a potential role to modulate cellular behavior, these miRNAs are among the best candidates to be developed in applications concerning regenerative medicine. As there has been increasing interest in demand for regenerative therapies, the miRNA market also tends to get investments in developing solutions concerning the miRNAs.
- Growing Awareness of miRNA's Potential in Agriculture: The microRNA market is not limited to the health sector alone but extends its benevolent hand towards agriculture too. miRNAs help in plant growth, stress resistance, and crop development. miRNA-based technologies are used for increasing crop yield, resistance to pests, and nutritional content, thereby contributing to agricultural produce. With advancing agricultural biotechnology, miRNA applications are of great importance and contribute to the overall growth of the market.
- Favorable Regulatory Environment: Also, miRNAs are helping support the diagnostics and therapeutics segment, leading to a relatively easier regulatory landscape to develop and bring to the market. In particular, increasing numbers of regulatory authorities such as the FDA in the United States and the EMA in Europe, appear increasingly favorable toward products utilizing miRNA, further streamlining market access. More favorably placed regulation also spurs investment into the research in the miRNAs area, accelerating market growth for companies involved in such activity.
- Development of miRNA-Based Vaccines: Another emerging trend in the MicroRNA (miRNA) market, is implemented into the market. miRNAs can regulate and change the immune responses of the organisms to increase effectiveness and strength; they therefore provide organisms with increased defense mechanisms against infections and diseases. With the increased vaccination demands around the world, especially post the COVID-19 pandemic, miRNA-based vaccine technologies offer the possibility of speedier, more targeted options and a new growth road for the miRNA market.
- Rise of miRNA Biomarkers in Liquid Biopsy: Liquid biopsy is an increasingly popular non-invasive diagnostic technique in the medical field, and miRNAs are playing a crucial role in this trend. miRNAs are mostly found in body fluids, such as blood, urine, and saliva and are great candidates for liquid biopsy; thus, the disease can be diagnosed and monitored at earlier stages for cancer diseases and cardiovascular diseases, and therefore, the growth in acceptance of technologies based on liquid biopsy will augment demand for miRNA-based biomarkers and this will increase the market for MicroRNA (miRNA).
- Personalized Medicine and Targeted Therapies: The future growth of the MicroRNA (miRNA) market has a strong nexus with the increased growth of targeted therapies and personalized medicines. Increasingly, in modern medicine, the function of miRNAs is becoming gradually recognized as it dictates the course and type of medication to be provided to a given patient based on their genetic makeup; therefore, personalization. Based on advancements achieved in genomic sequencing and bioinformatics, miRNA-based solutions may become the corner stone in the arena of personalized medicine-precise effective, and low-invasive.
- Emergence of miRNA in Agriculture and Plant Biotechnology: The agriculture sector has already adopted miRNAs and will expand in the coming years. In agriculture, miRNAs have been utilized to enhance crop yield, pest resistance, and tolerance to stress in plants. Due to food security being a massive issue worldwide, the demand for genetically modified crops and advanced agricultural solutions will raise the adoption of miRNA technologies. Agricultural application is one of the biggest opportunities for microRNA.
- Advances in miRNA Delivery Systems: Although the delivery aspect did pose some earlier concerns, this has now turned out to be one of the major bottlenecks of the miRNA field. There is some significant progress made concerning the delivery systems comprising lipid nanoparticles, viral vectors, and exosomes that would promise higher efficiency along with specificity in the targeting of the miRNA-based therapeutics. These innovations will make the miRNA-based treatments both more effective and less likely to cause side effects, making them clinically and commercially more viable. Hence, the need for these delivery systems will lead to an expansion of the microRNA (miRNA) market.
- Increased Collaboration Between Academia and Industry: Since the scope of applications for miRNAs is expanding, it will lead to the increasing collaboration of academic research institutions with industry players. These collaborations will bring novel miRNA-based therapies, diagnostics, and technologies to the fore. Partnerships between biotechnology companies, pharmaceutical firms, and academic institutions are expected to quicken the innovative pace of the miRNA market, thus inviting better products and solutions to come onto the market. Trendlines are likely to strengthen the growth track of the miRNA market further.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the MicroRNA (miRNA) Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the MicroRNA (miRNA) Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The MicroRNA (miRNA) Market is expected to register a CAGR of 13% from 2025-2031.
The major factors impacting the MicroRNA (miRNA) Market are: Expanding Applications in Regenerative Medicine, Growing Awareness of miRNA's Potential in Agriculture and Favorable Regulatory Environment
Key future trends in this market are - Development of miRNA-Based Vaccines, Rise of miRNA Biomarkers in Liquid Biopsy and Personalized Medicine and Targeted Therapies
Key companies of this market are: Merck KGaA, Thermo Fisher Scientific, Inc., Horizon Discovery Ltd., Synlogic, QIAGEN, GeneCopoeia, Inc., New England Biolabs, Quantabio, NanoString
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 MicroRNA (miRNA) Market - By Product
1.3.2 MicroRNA (miRNA) Market - By Services
1.3.3 MicroRNA (miRNA) Market - By Application
1.3.4 MicroRNA (miRNA) Market - By End User
1.3.5 MicroRNA (miRNA) Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MICRORNA (MIRNA) MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MICRORNA (MIRNA) MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MICRORNA (MIRNA) MARKET - GLOBAL MARKET ANALYSIS
6.1. MICRORNA (MIRNA) - GLOBAL MARKET OVERVIEW
6.2. MICRORNA (MIRNA) - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. MICRORNA (MIRNA) MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENTS
7.3.1. Overview
7.3.2. Instruments Market Forecast and Analysis
7.4. CONSUMABLES
7.4.1. Overview
7.4.2. Consumables Market Forecast and Analysis
7.4.3. Isolation and Purification Market
7.4.3.1. Overview
7.4.3.2. Isolation and Purification Market Forecast and Analysis
7.4.4. Quantification and Detection Market
7.4.4.1. Overview
7.4.4.2. Quantification and Detection Market Forecast and Analysis
7.4.5. Functional Analysis Market
7.4.5.1. Overview
7.4.5.2. Functional Analysis Market Forecast and Analysis
7.4.6. Others Market
7.4.6.1. Overview
7.4.6.2. Others Market Forecast and Analysis
8. MICRORNA (MIRNA) MARKET - REVENUE AND FORECASTS TO 2028 - SERVICES
8.1. OVERVIEW
8.2. SERVICES MARKET FORECASTS AND ANALYSIS
8.3. SAMPLE COLLECTION
8.3.1. Overview
8.3.2. Sample Collection Market Forecast and Analysis
8.3.3. Whole blood Market
8.3.3.1. Overview
8.3.3.2. Whole blood Market Forecast and Analysis
8.3.4. Serum Market
8.3.4.1. Overview
8.3.4.2. Serum Market Forecast and Analysis
8.3.5. Plasma Market
8.3.5.1. Overview
8.3.5.2. Plasma Market Forecast and Analysis
8.4. MIRNA CDNA SYNTHESIS
8.4.1. Overview
8.4.2. miRNA cDNA Synthesis Market Forecast and Analysis
8.5. MIRNA PROFILING AND PURIFICATION
8.5.1. Overview
8.5.2. miRNA Profiling and Purification Market Forecast and Analysis
8.6. NEXT GENERATION SEQUENCING (NGS)
8.6.1. Overview
8.6.2. Next Generation Sequencing (NGS) Market Forecast and Analysis
8.7. MICROARRAY
8.7.1. Overview
8.7.2. Microarray Market Forecast and Analysis
8.8. REAL TIME PCR (RT-PCR)
8.8.1. Overview
8.8.2. Real Time PCR (RT-PCR) Market Forecast and Analysis
8.9. OTHERS
8.9.1. Overview
8.9.2. Others Market Forecast and Analysis
9. MICRORNA (MIRNA) MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. CARDIOVASCULAR DISEASES
9.3.1. Overview
9.3.2. Cardiovascular Diseases Market Forecast and Analysis
9.4. CANCER
9.4.1. Overview
9.4.2. Cancer Market Forecast and Analysis
9.5. NEUROLOGICAL DISEASES
9.5.1. Overview
9.5.2. Neurological Diseases Market Forecast and Analysis
9.6. IMMUNOLOGICAL DISORDERS
9.6.1. Overview
9.6.2. Immunological Disorders Market Forecast and Analysis
9.7. INFECTIOUS DISEASES
9.7.1. Overview
9.7.2. Infectious Diseases Market Forecast and Analysis
9.8. OTHERS
9.8.1. Overview
9.8.2. Others Market Forecast and Analysis
10. MICRORNA (MIRNA) MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
10.3.1. Overview
10.3.2. Biotechnology and Pharmaceutical Companies Market Forecast and Analysis
10.4. ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES
10.4.1. Overview
10.4.2. Academic and Government Research Institutes Market Forecast and Analysis
10.5. OTHERS
10.5.1. Overview
10.5.2. Others Market Forecast and Analysis
11. MICRORNA (MIRNA) MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America MicroRNA (miRNA) Market Overview
11.1.2 North America MicroRNA (miRNA) Market Forecasts and Analysis
11.1.3 North America MicroRNA (miRNA) Market Forecasts and Analysis - By Product
11.1.4 North America MicroRNA (miRNA) Market Forecasts and Analysis - By Services
11.1.5 North America MicroRNA (miRNA) Market Forecasts and Analysis - By Application
11.1.6 North America MicroRNA (miRNA) Market Forecasts and Analysis - By End User
11.1.7 North America MicroRNA (miRNA) Market Forecasts and Analysis - By Countries
11.1.7.1 United States MicroRNA (miRNA) Market
11.1.7.1.1 United States MicroRNA (miRNA) Market by Product
11.1.7.1.2 United States MicroRNA (miRNA) Market by Services
11.1.7.1.3 United States MicroRNA (miRNA) Market by Application
11.1.7.1.4 United States MicroRNA (miRNA) Market by End User
11.1.7.2 Canada MicroRNA (miRNA) Market
11.1.7.2.1 Canada MicroRNA (miRNA) Market by Product
11.1.7.2.2 Canada MicroRNA (miRNA) Market by Services
11.1.7.2.3 Canada MicroRNA (miRNA) Market by Application
11.1.7.2.4 Canada MicroRNA (miRNA) Market by End User
11.1.7.3 Mexico MicroRNA (miRNA) Market
11.1.7.3.1 Mexico MicroRNA (miRNA) Market by Product
11.1.7.3.2 Mexico MicroRNA (miRNA) Market by Services
11.1.7.3.3 Mexico MicroRNA (miRNA) Market by Application
11.1.7.3.4 Mexico MicroRNA (miRNA) Market by End User
11.2. EUROPE
11.2.1 Europe MicroRNA (miRNA) Market Overview
11.2.2 Europe MicroRNA (miRNA) Market Forecasts and Analysis
11.2.3 Europe MicroRNA (miRNA) Market Forecasts and Analysis - By Product
11.2.4 Europe MicroRNA (miRNA) Market Forecasts and Analysis - By Services
11.2.5 Europe MicroRNA (miRNA) Market Forecasts and Analysis - By Application
11.2.6 Europe MicroRNA (miRNA) Market Forecasts and Analysis - By End User
11.2.7 Europe MicroRNA (miRNA) Market Forecasts and Analysis - By Countries
11.2.7.1 Germany MicroRNA (miRNA) Market
11.2.7.1.1 Germany MicroRNA (miRNA) Market by Product
11.2.7.1.2 Germany MicroRNA (miRNA) Market by Services
11.2.7.1.3 Germany MicroRNA (miRNA) Market by Application
11.2.7.1.4 Germany MicroRNA (miRNA) Market by End User
11.2.7.2 France MicroRNA (miRNA) Market
11.2.7.2.1 France MicroRNA (miRNA) Market by Product
11.2.7.2.2 France MicroRNA (miRNA) Market by Services
11.2.7.2.3 France MicroRNA (miRNA) Market by Application
11.2.7.2.4 France MicroRNA (miRNA) Market by End User
11.2.7.3 Italy MicroRNA (miRNA) Market
11.2.7.3.1 Italy MicroRNA (miRNA) Market by Product
11.2.7.3.2 Italy MicroRNA (miRNA) Market by Services
11.2.7.3.3 Italy MicroRNA (miRNA) Market by Application
11.2.7.3.4 Italy MicroRNA (miRNA) Market by End User
11.2.7.4 Spain MicroRNA (miRNA) Market
11.2.7.4.1 Spain MicroRNA (miRNA) Market by Product
11.2.7.4.2 Spain MicroRNA (miRNA) Market by Services
11.2.7.4.3 Spain MicroRNA (miRNA) Market by Application
11.2.7.4.4 Spain MicroRNA (miRNA) Market by End User
11.2.7.5 United Kingdom MicroRNA (miRNA) Market
11.2.7.5.1 United Kingdom MicroRNA (miRNA) Market by Product
11.2.7.5.2 United Kingdom MicroRNA (miRNA) Market by Services
11.2.7.5.3 United Kingdom MicroRNA (miRNA) Market by Application
11.2.7.5.4 United Kingdom MicroRNA (miRNA) Market by End User
11.2.7.6 Rest of Europe MicroRNA (miRNA) Market
11.2.7.6.1 Rest of Europe MicroRNA (miRNA) Market by Product
11.2.7.6.2 Rest of Europe MicroRNA (miRNA) Market by Services
11.2.7.6.3 Rest of Europe MicroRNA (miRNA) Market by Application
11.2.7.6.4 Rest of Europe MicroRNA (miRNA) Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific MicroRNA (miRNA) Market Overview
11.3.2 Asia-Pacific MicroRNA (miRNA) Market Forecasts and Analysis
11.3.3 Asia-Pacific MicroRNA (miRNA) Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific MicroRNA (miRNA) Market Forecasts and Analysis - By Services
11.3.5 Asia-Pacific MicroRNA (miRNA) Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific MicroRNA (miRNA) Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific MicroRNA (miRNA) Market Forecasts and Analysis - By Countries
11.3.7.1 Australia MicroRNA (miRNA) Market
11.3.7.1.1 Australia MicroRNA (miRNA) Market by Product
11.3.7.1.2 Australia MicroRNA (miRNA) Market by Services
11.3.7.1.3 Australia MicroRNA (miRNA) Market by Application
11.3.7.1.4 Australia MicroRNA (miRNA) Market by End User
11.3.7.2 China MicroRNA (miRNA) Market
11.3.7.2.1 China MicroRNA (miRNA) Market by Product
11.3.7.2.2 China MicroRNA (miRNA) Market by Services
11.3.7.2.3 China MicroRNA (miRNA) Market by Application
11.3.7.2.4 China MicroRNA (miRNA) Market by End User
11.3.7.3 India MicroRNA (miRNA) Market
11.3.7.3.1 India MicroRNA (miRNA) Market by Product
11.3.7.3.2 India MicroRNA (miRNA) Market by Services
11.3.7.3.3 India MicroRNA (miRNA) Market by Application
11.3.7.3.4 India MicroRNA (miRNA) Market by End User
11.3.7.4 Japan MicroRNA (miRNA) Market
11.3.7.4.1 Japan MicroRNA (miRNA) Market by Product
11.3.7.4.2 Japan MicroRNA (miRNA) Market by Services
11.3.7.4.3 Japan MicroRNA (miRNA) Market by Application
11.3.7.4.4 Japan MicroRNA (miRNA) Market by End User
11.3.7.5 South Korea MicroRNA (miRNA) Market
11.3.7.5.1 South Korea MicroRNA (miRNA) Market by Product
11.3.7.5.2 South Korea MicroRNA (miRNA) Market by Services
11.3.7.5.3 South Korea MicroRNA (miRNA) Market by Application
11.3.7.5.4 South Korea MicroRNA (miRNA) Market by End User
11.3.7.6 Rest of Asia-Pacific MicroRNA (miRNA) Market
11.3.7.6.1 Rest of Asia-Pacific MicroRNA (miRNA) Market by Product
11.3.7.6.2 Rest of Asia-Pacific MicroRNA (miRNA) Market by Services
11.3.7.6.3 Rest of Asia-Pacific MicroRNA (miRNA) Market by Application
11.3.7.6.4 Rest of Asia-Pacific MicroRNA (miRNA) Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa MicroRNA (miRNA) Market Overview
11.4.2 Middle East and Africa MicroRNA (miRNA) Market Forecasts and Analysis
11.4.3 Middle East and Africa MicroRNA (miRNA) Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa MicroRNA (miRNA) Market Forecasts and Analysis - By Services
11.4.5 Middle East and Africa MicroRNA (miRNA) Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa MicroRNA (miRNA) Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa MicroRNA (miRNA) Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa MicroRNA (miRNA) Market
11.4.7.1.1 South Africa MicroRNA (miRNA) Market by Product
11.4.7.1.2 South Africa MicroRNA (miRNA) Market by Services
11.4.7.1.3 South Africa MicroRNA (miRNA) Market by Application
11.4.7.1.4 South Africa MicroRNA (miRNA) Market by End User
11.4.7.2 Saudi Arabia MicroRNA (miRNA) Market
11.4.7.2.1 Saudi Arabia MicroRNA (miRNA) Market by Product
11.4.7.2.2 Saudi Arabia MicroRNA (miRNA) Market by Services
11.4.7.2.3 Saudi Arabia MicroRNA (miRNA) Market by Application
11.4.7.2.4 Saudi Arabia MicroRNA (miRNA) Market by End User
11.4.7.3 U.A.E MicroRNA (miRNA) Market
11.4.7.3.1 U.A.E MicroRNA (miRNA) Market by Product
11.4.7.3.2 U.A.E MicroRNA (miRNA) Market by Services
11.4.7.3.3 U.A.E MicroRNA (miRNA) Market by Application
11.4.7.3.4 U.A.E MicroRNA (miRNA) Market by End User
11.4.7.4 Rest of Middle East and Africa MicroRNA (miRNA) Market
11.4.7.4.1 Rest of Middle East and Africa MicroRNA (miRNA) Market by Product
11.4.7.4.2 Rest of Middle East and Africa MicroRNA (miRNA) Market by Services
11.4.7.4.3 Rest of Middle East and Africa MicroRNA (miRNA) Market by Application
11.4.7.4.4 Rest of Middle East and Africa MicroRNA (miRNA) Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America MicroRNA (miRNA) Market Overview
11.5.2 South and Central America MicroRNA (miRNA) Market Forecasts and Analysis
11.5.3 South and Central America MicroRNA (miRNA) Market Forecasts and Analysis - By Product
11.5.4 South and Central America MicroRNA (miRNA) Market Forecasts and Analysis - By Services
11.5.5 South and Central America MicroRNA (miRNA) Market Forecasts and Analysis - By Application
11.5.6 South and Central America MicroRNA (miRNA) Market Forecasts and Analysis - By End User
11.5.7 South and Central America MicroRNA (miRNA) Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil MicroRNA (miRNA) Market
11.5.7.1.1 Brazil MicroRNA (miRNA) Market by Product
11.5.7.1.2 Brazil MicroRNA (miRNA) Market by Services
11.5.7.1.3 Brazil MicroRNA (miRNA) Market by Application
11.5.7.1.4 Brazil MicroRNA (miRNA) Market by End User
11.5.7.2 Argentina MicroRNA (miRNA) Market
11.5.7.2.1 Argentina MicroRNA (miRNA) Market by Product
11.5.7.2.2 Argentina MicroRNA (miRNA) Market by Services
11.5.7.2.3 Argentina MicroRNA (miRNA) Market by Application
11.5.7.2.4 Argentina MicroRNA (miRNA) Market by End User
11.5.7.3 Rest of South and Central America MicroRNA (miRNA) Market
11.5.7.3.1 Rest of South and Central America MicroRNA (miRNA) Market by Product
11.5.7.3.2 Rest of South and Central America MicroRNA (miRNA) Market by Services
11.5.7.3.3 Rest of South and Central America MicroRNA (miRNA) Market by Application
11.5.7.3.4 Rest of South and Central America MicroRNA (miRNA) Market by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL MICRORNA (MIRNA) MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. MICRORNA (MIRNA) MARKET, KEY COMPANY PROFILES
14.1. MERCK KGAA
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. THERMO FISHER SCIENTIFIC INC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. QIAGEN
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. GENECOPOEIA, INC.
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. BIOGENEX
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. NANOSTRING TECHNOLOGIES, INC.
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. SYNLOGIC
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. HORIZON DISCOVERY LTD
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. SEQMATIC LLC.
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. QUANTABIO
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
1. Merck KGaA
2. Thermo Fisher Scientific, Inc.
3. Horizon Discovery Ltd.
4. Synlogic
5. QIAGEN
6. GeneCopoeia, Inc.
7. New England Biolabs
8. Quantabio
9. NanoString
10. BioGenex
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For